Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

Completed

Conditions studied: Mycosis Fungoides

In brief

The Valchlor PROVe study is a multi-center, prospective, observational, US-based drug study that longitudinally follows patients with Mycosis Fungoides Cutaneous T-cell Lymphoma (MF-CTCL) who are receiving therapy with Valchlor. Patients will be followed prospectively for a maximum of 2 years from the date of signed informed consent (enrollment) until end of study. Continuation in the study is not contingent on continuation of Valchlor.

Key facts

Study ID

NCT02296164

Run by

Helsinn Therapeutics (U.S.), Inc

People needed

300

Starts

2014-11-12

Expected to finish

2018-10-17

Last updated by the study team

2020-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All adult patients (≥ 18 years of age) diagnosed with MF CTCL and being treated with Valchlor. This includes patients newly initiating Valchlor OR patients continuing treatment with Valchlor:
• Patients newly initiating Valchlor are patients who have their first office visit after having initiated Valchlor.
• Patients continuing treatment with Valchlor includes patients who are actively taking Valchlor on the day of enrollment.
• Signed patient informed consent.

You may not qualify if…

• None

Where it is running

• Investigator Site — Little Rock, Arkansas, United States
• Investigator Site — Duarte, California, United States
• Investigator Site — La Mesa, California, United States
• Investigator Site — San Francisco, California, United States
• Investigator Site — Santa Ana, California, United States
• Investigator Site — Aurora, Colorado, United States
• Investigator Site — New Haven, Connecticut, United States
• Investigator Site — Coral Gables, Florida, United States
• Investigator Site — Hollywood, Florida, United States
• Investigator Site — Naples, Florida, United States
• Investigator Site — Tampa, Florida, United States
• Investigator Site — Atlanta, Georgia, United States
• Investigator Site — Chicago, Illinois, United States
• Investigator Site — Chicago, Illinois, United States
• Investigator Site — Chicago, Illinois, United States
• Investigator Site — New Orleans, Louisiana, United States
• Investigator Site — Boston, Massachusetts, United States
• Investigator Site — Ann Arbor, Michigan, United States
• Investigator Site — Jackson, Mississippi, United States
• Investigator Site — St Louis, Missouri, United States
• Investigator Site — St Louis, Missouri, United States
• Investigator Site — Henderson, Nevada, United States
• Investigator Site — East Windsor, New Jersey, United States
• Investigator Site — Brooklyn, New York, United States
• Investigator Site — Fairport, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.